Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.

Molleston JP, Fontana RJ, Lopez MJ, Kleiner DE, Gu J, Chalasani N; Drug-Induced Liver Injury Network.

J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):182-9. doi: 10.1097/MPG.0b013e31821d6cfd.

2.

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J; United States Drug Induced Liver Injury Network.

Gastroenterology. 2015 Jun;148(7):1340-52.e7. doi: 10.1053/j.gastro.2015.03.006. Epub 2015 Mar 6.

3.

Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience.

Ghabril M, Fontana R, Rockey D, Jiezhun G, Chalasani N.

J Clin Gastroenterol. 2013 Jul;47(6):553-8. doi: 10.1097/MCG.0b013e318276bf00.

4.

Drug-induced liver injury.

Leise MD, Poterucha JJ, Talwalkar JA.

Mayo Clin Proc. 2014 Jan;89(1):95-106. doi: 10.1016/j.mayocp.2013.09.016. Review.

PMID:
24388027
5.

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.

Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J; DILIN Study Group.

Drug Saf. 2009;32(1):55-68. doi: 10.2165/00002018-200932010-00005.

6.

Amoxicillin-Clavulanate-Induced Liver Injury.

deLemos AS, Ghabril M, Rockey DC, Gu J, Barnhart HX, Fontana RJ, Kleiner DE, Bonkovsky HL; Drug-Induced Liver Injury Network (DILIN).

Dig Dis Sci. 2016 Aug;61(8):2406-16. doi: 10.1007/s10620-016-4121-6. Epub 2016 Mar 22.

7.

An update on drug induced liver injury.

Rangnekar AS, Fontana RJ.

Minerva Gastroenterol Dietol. 2011 Jun;57(2):213-29. Review.

PMID:
21587150
8.

Clinical and histologic features of azithromycin-induced liver injury.

Martinez MA, Vuppalanchi R, Fontana RJ, Stolz A, Kleiner DE, Hayashi PH, Gu J, Hoofnagle JH, Chalasani N.

Clin Gastroenterol Hepatol. 2015 Feb;13(2):369-376.e3. doi: 10.1016/j.cgh.2014.07.054. Epub 2014 Aug 9.

9.

Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.

Fontana RJ, Hayashi PH, Barnhart H, Kleiner DE, Reddy KR, Chalasani N, Lee WM, Stolz A, Phillips T, Serrano J, Watkins PB; DILIN Investigators.

Am J Gastroenterol. 2015 Oct;110(10):1450-9. doi: 10.1038/ajg.2015.283. Epub 2015 Sep 8.

10.

Idiosyncratic Drug Induced Liver Injury in African-Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians.

Chalasani N, Reddy KRK, Fontana RJ, Barnhart H, Gu J, Hayashi PH, Ahmad J, Stolz A, Navarro V, Hoofnagle JH.

Am J Gastroenterol. 2017 Sep;112(9):1382-1388. doi: 10.1038/ajg.2017.215. Epub 2017 Aug 1.

11.

Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.

Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwakar JA; DILIN Network.

Gastroenterology. 2014 Jul;147(1):96-108.e4. doi: 10.1053/j.gastro.2014.03.045. Epub 2014 Mar 27.

12.

Serum proteomic profiling in patients with drug-induced liver injury.

Bell LN, Vuppalanchi R, Watkins PB, Bonkovsky HL, Serrano J, Fontana RJ, Wang M, Rochon J, Chalasani N; US Drug-Induced Liver Injury Network (DILIN) Research Group.

Aliment Pharmacol Ther. 2012 Mar;35(5):600-12.

13.

Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Orman ES, Conjeevaram HS, Vuppalanchi R, Freston JW, Rochon J, Kleiner DE, Hayashi PH; DILIN Research Group.

Clin Gastroenterol Hepatol. 2011 Jun;9(6):517-523.e3. doi: 10.1016/j.cgh.2011.02.019. Epub 2011 Feb 26.

14.

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN).

Gastroenterology. 2008 Dec;135(6):1924-34, 1934.e1-4. doi: 10.1053/j.gastro.2008.09.011. Epub 2008 Sep 17.

15.

Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation.

Sembera S, Lammert C, Talwalkar JA, Sanderson SO, Poterucha JJ, Hay JE, Wiesner RH, Gores GJ, Rosen CB, Heimbach JK, Charlton MR.

Liver Transpl. 2012 Jul;18(7):803-10. doi: 10.1002/lt.23424.

16.

[Clinical and pathological features in 138 cases of drug-induced liver injury].

Lai RT, Wang H, Gui HL, Ye MZ, Dai WJ, Xiang XG, Zhao GD, Wang WJ, Xie Q.

Zhonghua Gan Zang Bing Za Zhi. 2012 Mar;20(3):185-9. doi: 10.3760/cma.j.issn.1007-3418.2012.03.009. Chinese.

PMID:
22475136
17.

Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.

Xu HM, Chen Y, Xu J, Zhou Q.

World J Gastroenterol. 2012 Nov 7;18(41):5972-8. doi: 10.3748/wjg.v18.i41.5972.

18.

Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.

Devarbhavi H, Karanth D, Prasanna KS, Adarsh CK, Patil M.

Hepatology. 2011 Oct;54(4):1344-50. doi: 10.1002/hep.24527. Epub 2011 Sep 6.

PMID:
21735470
19.

Idiosyncratic drug-induced liver injury: an overview.

Hussaini SH, Farrington EA.

Expert Opin Drug Saf. 2007 Nov;6(6):673-84. Review.

PMID:
17967156
20.

Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.

Russo MW, Hoofnagle JH, Gu J, Fontana RJ, Barnhart H, Kleiner DE, Chalasani N, Bonkovsky HL.

Hepatology. 2014 Aug;60(2):679-86. doi: 10.1002/hep.27157. Epub 2014 May 13.

Supplemental Content

Support Center